Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction

被引:9
|
作者
Zhang, Xiaojia [1 ]
Hu, Liangping [1 ,2 ]
Zheng, Wen [3 ]
机构
[1] Acad Mil Med Sci, Consulting Ctr Biomed Stat, Beijing 100850, Peoples R China
[2] Specialty Comm Clin Sci Res Stat World Federat Ch, Beijing 100029, Peoples R China
[3] Capital Med Univ, Beijing Anzhen Hosp, Beijing 100029, Peoples R China
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
基金
国家高技术研究发展计划(863计划);
关键词
CHRONIC KIDNEY-DISEASE; IN-HOSPITAL OUTCOMES; FOLLOW-UP; REVASCULARIZATION; SURGERY; IMPACT; ANGIOPLASTY; POPULATION; MORTALITY; EVENTS;
D O I
10.1038/s41598-018-20651-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ACS patients with renal dysfunction tend to have a poorer prognosis than those with normal renal function. This retrospective cohort study was performed using The Second Drug-Eluting Stent Impact on Revascularization Registry, a retrospective registry, to evaluate the time-dependent relative risk of revascularization strategies in ACS patients with renal dysfunction. The study demonstrated that the short-term MACCE rate was lower after PCI than CABG. However, there was no significant difference in long-term MACCE rate. Subgroup analyses based on the degree of renal dysfunction resulted in similar findings. The revascularization strategy was identified as a time-dependent covariate by the time-dependent Cox model, and the regression coefficient was '-1.124 + 0.344 x ln (time + 1)'. For the entire object group and the separate subgroups, PCI was initially associated with a lower hazard for MACCE than CABG after revascularization, then the hazard ratio increases with time. In conclusion, the hazard ratio for MACCE in PCI relative to CABG is time-dependent. PCI tends to have a lower risk for MACCE than CABG in the short-term, then the hazard ratio increases with time.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [41] COMPARISON OF OUTCOMES WITH CORONARY ARTERY BYPASS GRAFT SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN IN DIABETIC PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE
    Yu Miao
    Zhou Yu-jie
    HEART, 2011, 97
  • [42] Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Severe Left Ventricle Dysfunction Reply
    Meyer, Steven R.
    ANNALS OF THORACIC SURGERY, 2014, 98 (05): : 1889 - 1889
  • [43] Coronary artery bypass graft surgery versus percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review
    Macovei, Liviu
    Magopet, Robert
    Tanasa, Ana
    Raileanu, Cezara
    Prisacariu, Cristina
    Presura, Mihai Razvan
    Balasanian, Mircea Ovanez
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (01) : 65 - 73
  • [44] Retrospective analysis of exercise capacity in patients with coronary artery disease after percutaneous coronary intervention or coronary artery bypass graft
    Ying Li
    Xue Feng
    Biyun Chen
    Huaping Liu
    International Journal of Nursing Sciences, 2021, 8 (03) : 257 - 263
  • [45] Retrospective analysis of exercise capacity in patients with coronary artery disease after percutaneous coronary intervention or coronary artery bypass graft
    Li, Ying
    Feng, Xue
    Chen, Biyun
    Liu, Huaping
    INTERNATIONAL JOURNAL OF NURSING SCIENCES, 2021, 8 (03) : 257 - 263
  • [46] Percutaneous Coronary Intervention with Stenting versus Coronary Artery Bypass Grafting in Stable Coronary Artery Disease
    Glenn, Ian C.
    Iacona, Gabriele M.
    Mangi, Abeel A.
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2021, 30 (03) : 221 - 227
  • [47] Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
    Serruys, Patrick W.
    Morice, Marie-Claude
    Kappetein, A. Pieter
    Colombo, Antonio
    Holmes, David R.
    Mack, Michael J.
    Stahle, Elisabeth
    Feldman, Ted E.
    van den Brand, Marcel
    Bass, Eric J.
    Van Dyck, Nic
    Leadley, Katrin
    Dawkins, Keith D.
    Mohr, Friedrich W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10): : 961 - 972
  • [48] The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease
    Godoy, Lucas C.
    Ko, Dennis T.
    Rao, Vivek
    Farkouh, Michael E.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (04) : 358 - 363
  • [49] Climbing the hill of left main coronary artery revascularization: percutaneous coronary intervention or coronary artery bypass graft?
    Indolfi, Ciro
    Spaccarotella, Carmen
    Yasuda, Masakazu
    De Rosa, Salvatore
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 576 - 580
  • [50] Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery
    Whellan, David J.
    Tricoci, Pierluigi
    Chen, Edmond
    Huang, Zhen
    Leibowitz, David
    Vranckx, Pascal
    Marhefka, Gregary D.
    Held, Claes
    Nicolau, Jose C.
    Storey, Robert F.
    Ruzyllo, Witold
    Huber, Kurt
    Sinnaeve, Peter
    Weiss, A. Teddy
    Dery, Jean-Pierre
    Moliterno, David J.
    Van de Werf, Frans
    Aylward, Philip E.
    White, Harvey D.
    Armstrong, Paul W.
    Wallentin, Lars
    Strony, John
    Harrington, Robert A.
    Mahaffey, Kenneth W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (11) : 1048 - 1057